This is also supported by the profile of expression of RSK3 in human breast tumors, which was strongly correlated with TGFβ signaling, EMT signature and invasion, and inversely correlated with cellular senescence and NF-κB signature in a large set of Claudin-low breast tumors. This evidence concerns the gene RPS6KA2 and breast neoplasm.